Translate Bio, Inc. (TBIO) has 51 open-market insider trades by 19 insiders since 2001. The most active filer is LeRoy C. Kopp, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Sanofi | 10% Owner | — | 1 | $2.7B | 2021-09-14 |
| Takeda Pharmaceutical Co. Ltd. | 10% Owner | — | 2 | $283.9M | 2020-06-30 |
| Jean Francois Formela | Dir | — | 3 | $83.7M | 2021-09-14 |
| Ronald C. Renaud Jr. | CEO | — | 1 | $36.3M | 2021-09-14 |
| Seth A. Klarman | 10% Owner | — | 1 | $11.0M | 2021-09-14 |
| Shire Human Genetic Therapies, Inc. | 10% Owner | — | 1 | $8.4M | 2020-06-02 |
| LeRoy C. Kopp | 10% | — | 28 | $7.6M | 2014-05-22 |
| Randal J. Kirk | 10% Owner | — | 2 | $6.4M | 2017-06-29 |
| Glaxosmithkline PLC | 10% Owner | — | 1 | $3.5M | 2018-07-02 |
| Brian M. Gallagher Jr. | Dir | — | 1 | $3.5M | 2018-07-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Rob Cutler | CLO | Sell | $3K | 2023-05-04 |
| Todd Robert Nelson | President & 10% | Sell | $7K | 2023-05-04 |
| Daniel Glenn Gibson | CTO | Sell | $3K | 2023-05-04 |
| Jean Francois Formela | Director | Sell | $78.1M | 2021-09-14 |
| Paul D. Burgess | COO & CLO | Sell | $2.7M | 2021-09-14 |
| Owen Hughes | Director | Sell | $1.1M | 2021-09-14 |
Companies that share insiders with TBIO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sanofi | 10% Owner | Buy | $2.7B | 2021-09-14 |
| Ronald C. Renaud Jr. | CEO | Sell | $36.3M | 2021-09-14 |
| Jean Francois Formela | Director | Sell | $5.5M | 2020-12-21 |
| Jean Francois Formela | Director | Sell | $2.1M | 2020-08-25 |
| Takeda Pharmaceutical Co. Ltd. | 10% Owner | Sell | $282.3M | 2020-06-30 |
| Seth A. Klarman | 10% Owner | Buy | $11.0M | 2020-06-26 |
| Takeda Pharmaceutical Co. Ltd. | 10% Owner | Sell | $1.6M | 2020-06-03 |
| Shire Human Genetic Therapies, Inc. | 10% Owner | Sell | $8.4M | 2020-06-01 |
| MRL Ventures Fund LLC | 10% Owner | Buy | $325K | 2018-07-02 |